Immune system protein may act as early warning system for lung cancer
November 14th, 2007 - 2:02 am ICT by admin
- They tested for autoantibodies, an immune system protein directed at the body’s own tissues in response to specific chemical signals in the body.
They looked specifically for a panel of seven autoantibodies, which are associated with ’solid tumours,’ such as lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes take place.
The analysis showed the presence of all the seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.
The autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, body’s gatekeepers.
The results indicated that the disease had not yet extended elsewhere and offered 80 percent chances of cure and only one healthy volunteer had more than one of the autoantibodies in their blood.
The study is published in the journal Thorax. (ANI)
Sphere: Related ContentRelated Stories
- Now, a potential HIV-test equivalent for early detection of lung cancer - Sep 16, 2008
- How women with lupus can boost their chances of healthy pregnancies - Oct 27, 2008
- Study shows pre-eclampsia may be an autoimmune disease - Jul 28, 2008
- Monoclonal antibodies can be used as potent immune weapons against cancer - Mar 22, 2009
- Drug therapy effective in immune-mediated kidney disease - Aug 06, 2008
- How ovarian tumours evade immune system - Dec 01, 2008
- Personalized treatment for early lung cancer on the anvil - May 04, 2009
- Taiwan researchers discover blood marker for metastatic cancer - May 20, 2009
- New marker to detect prostate cancer identified - Mar 26, 2009
- New approach to treat lung cancer offers high cure rates - Mar 05, 2009
- Health
Posted in Health, |
January 10th, 2008 at 9:20 pm
Great work. Now there needs to be an “X-Prize” type award for cancer researchers to stop this endless research and bring it to a point.